Literature DB >> 21183558

Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil.

M Oliveira-Santos1, J F S Verani, E M Klumb, E M N Albuquerque.   

Abstract

The objectives of this study were to measure the prevalence of adherence to drug treatment and analyze associations with characteristics pertaining to the treatment, disease, health professionals and services, and socio-demographic issues in patients with systemic lupus erythematosus (SLE) in the city of Rio de Janeiro, Brazil. A sample of 246 women with SLE was analyzed. The data were collected through individual interviews and a review of patient charts. Adherence was estimated according to the Morisk criteria, and the associated factors were analyzed by hierarchical modeling. The percentage of patients classified as adherent to treatment was 31.7%. The reasons cited for non-adherence were: carelessness with drug administration times (52.43%), forgetfulness (38.21%), adverse drug reaction (13.8%), and interruption of treatment due to improvement in symptoms (7.72%). Factors associated with adherence were: behavior towards the presence of adverse drug reaction, hematological alterations, presence of mucocutaneous manifestations, legibility of the medical prescription, schooling, and family support. The study concludes that adherence to drug treatment in SLE is a complex and multifactorial phenomenon, and the results corroborate findings from studies conducted in developed countries. The hierarchical modeling proved to be a good alternative for evaluating adherence, since it allowed visualizing the various stages in the analysis.

Entities:  

Mesh:

Year:  2010        PMID: 21183558     DOI: 10.1177/0961203310383736

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  17 in total

1.  Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence.

Authors:  Laura Durcan; William A Clarke; Laurence S Magder; Michelle Petri
Journal:  J Rheumatol       Date:  2015-10-01       Impact factor: 4.666

2.  A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Authors:  Nathalie Costedoat-Chalumeau; Frédéric Houssiau; Peter Izmirly; Véronique Le Guern; Sandra Navarra; Meenakshi Jolly; Guillermo Ruiz-Irastorza; Gabriel Baron; Eric Hachulla; Nancy Agmon-Levin; Yehuda Shoenfeld; Francesca Dall'Ara; Jill Buyon; Christophe Deligny; Ricard Cervera; Estibaliz Lazaro; Holy Bezanahary; Gaëlle Leroux; Nathalie Morel; Jean-François Viallard; Christian Pineau; Lionel Galicier; Ronald Van Vollenhoven; Angela Tincani; Hanh Nguyen; Guillaume Gondran; Noel Zahr; Jacques Pouchot; Jean-Charles Piette; Michelle Petri; David Isenberg
Journal:  Clin Pharmacol Ther       Date:  2017-11-09       Impact factor: 6.875

Review 3.  The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.

Authors:  Natasha K J Campbell; Khalid Saadeldin; Mary A De Vera
Journal:  Curr Rheumatol Rep       Date:  2017-09-18       Impact factor: 4.592

4.  Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.

Authors:  Candace H Feldman; Jinoos Yazdany; Hongshu Guan; Daniel H Solomon; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-12       Impact factor: 4.794

Review 5.  Resolutive pulmonary endarterectomy in a non-compliant patient with systemic lupus erythematosus and antiphospholipid syndrome.

Authors:  Anna Kuzenko; Savino Sciascia; Erika Silvestro; Iuliana Badiu; Marco Morsolini; Maria Elena Rovere; Maria Tiziana Bertero
Journal:  Rheumatol Int       Date:  2012-01-06       Impact factor: 2.631

6.  Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus.

Authors:  Candace H Feldman; Jamie Collins; Zhi Zhang; S V Subramanian; Daniel H Solomon; Ichiro Kawachi; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2018-01-08       Impact factor: 5.532

7.  Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized.

Authors:  Michael E Farhangian; William W Huang; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2015-04-22

8.  The Lived Experience of Lupus Flares: Features, Triggers, and Management in an Australian Female Cohort.

Authors:  Marline L Squance; Glenn E M Reeves; Howard Bridgman
Journal:  Int J Chronic Dis       Date:  2014-11-20

9.  An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Vitor Cavalcanti Trindade; Magda Carneiro-Sampaio; Eloisa Bonfa; Clovis Artur Silva
Journal:  Paediatr Drugs       Date:  2021-07-10       Impact factor: 3.022

10.  Resilience and treatment adhesion in patients with systemic lupus erythematosus.

Authors:  Daniella Antunes Pousa Faria; Luciana Silva Revoredo; Maria José Vilar; Maia Eulália Maria Chaves
Journal:  Open Rheumatol J       Date:  2014-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.